Morgan Stanley Upgrades Loxo On The Potential Of A Targeted Cancer Therapy
April 16, 2018 at 09:52 AM EDT
Loxo Oncology Inc (NASDAQ: LOXO) holds an opportunity to differentiate itself among RET inhibitors while developing medicines for ...
